Author:
Wei Cynthia X.,Mamdani Hirva,Gentzler Ryan,Kalra Maitri,Perkins Susan,Althouse Sandra,Jalal Shadia I.
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference15 articles.
1. Cancer Stat Facts: Lung and Bronchus Cancer. National cancer institute. https://seer.cancer.gov/statfacts/html/lungb.html, 09/10/2022.
2. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial;Paz-Ares;Lancet,2019
3. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer;Horn;N Engl J Med,2018
4. Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial;Trigo;Lancet Oncol,2020
5. ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line;Farago;Future Oncol,2019